Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd. (also referenced as Quoin Pharmaceuticals, Ltd. in metadata) on August 22, 2019, covering the month of August 2019. The registrant is a foreign private issuer based in Kfar Saba, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements.
Material Changes
The primary material change disclosed is the resignation of Ruhama Avraham as a director of the company, effective immediately on August 20, 2019. The resignation was to allow her to focus on a newly appointed position.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the director resignation.
Key Facts for Investor Verification
- Confirm the identity of the new director appointed to replace Ruhama Avraham, if applicable.
- Verify the impact of the director resignation on the company's board composition and governance.
- Review subsequent filings for any financial updates, as this document contains no financial data.